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Abstract: Ene reductases enable the asymmetric hydrogenation of activated alkenes allowing the
manufacture of valuable chiral products. The enzymes complement existing metal- and organocatalytic
approaches for the stereoselective reduction of activated C=C double bonds, and efforts to expand the
biocatalytic toolbox with additional ene reductases are of high academic and industrial interest. Here,
we present the characterization of a novel ene reductase from Paenibacillus polymyxa, named Ppo-Er1,
belonging to the recently identified subgroup III of the old yellow enzyme family. The determination
of substrate scope, solvent stability, temperature, and pH range of Ppo-Er1 is one of the first examples
of a detailed biophysical characterization of a subgroup III enzyme. Notably, Ppo-Er1 possesses a wide
temperature optimum (Topt: 20–45 ◦C) and retains high conversion rates of at least 70% even at 10 ◦C
reaction temperature making it an interesting biocatalyst for the conversion of temperature-labile
substrates. When assaying a set of different organic solvents to determine Ppo-Er1′s solvent tolerance,
the ene reductase exhibited good performance in up to 40% cyclohexane as well as 20 vol% DMSO
and ethanol. In summary, Ppo-Er1 exhibited activity for thirteen out of the nineteen investigated
compounds, for ten of which Michaelis–Menten kinetics could be determined. The enzyme exhibited
the highest specificity constant for maleimide with a kcat/KM value of 287 mM−1 s−1. In addition,
Ppo-Er1 proved to be highly enantioselective for selected substrates with measured enantiomeric
excess values of 92% or higher for 2-methyl-2-cyclohexenone, citral, and carvone.
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1. Introduction
Many bioactive molecules contain at least one chiral center rendering the development of effective
asymmetric synthesis methods essential for the chemical industry. Besides the well-established
metal- and organocatalytic approaches [1], biocatalytic strategies offer an interesting alternative to
install chirality into small molecules. To date, industrial biocatalysis has mastered a range of enzyme
families including ketoreductases [2], transaminases [3], and imine reductases [4]. Looking forward,
the increasing power of genomic mining and enzyme engineering will allow industrial access to even
more enzyme families leading to an expansion of the available biocatalytic toolbox [5].
The families of enzymes collectively known as ene reductases (ERs) catalyze the stereoselective
trans- and, more rarely, cis-hydrogenation of activated alkenes [6–9]. Thus, ene reductases offer
a valuable access route to asymmetric compounds, which is complementary to the chemical
cis-hydrogenation catalyzed by chiral rhodium or ruthenium phosphine catalysts [10,11]. Today,
ene reductases are classified into five enzyme groups, which differ in structure, reaction mechanism,
substrate spectrum, and stereoselectivity (Figure 1) [12]. While enoate reductases, medium- and
short-chain dehydrogenases/reductases (MDR and SDR), as well as the recently discovered quinone
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reductase-like ene reductases [13], are currently being investigated in terms of their industrial
potential [14], enzymes stemming from the old yellow enzyme (OYE) family are established members
of the biocatalytic toolbox and are the best characterized and most extensively employed ene reductases
today [6].
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Figure 1. Overview of the classification within the ene reductase family [15]. QnoR (NADPH-
dependent quinone reductase like ene-reductases), EnoR (enoate reductase), OYE (old yellow 
enzyme), MDR (medium-chain dehydrogenase/reductase), and SDR (short-chain 
dehydrogenase/reductase); Class I (classical OYE); Class II (thermophilic-like OYE) and Class V 
(fungal OYE). 
Isolated in 1932 by Warburg and Christian from bottom-fermented brewer’s yeast 
(Saccharomyces pastorianus), the first such ene reductase was named “yellow enzyme” [16]. After the 
discovery of several additional members belonging to the same enzyme family the “yellow enzyme” 
was renamed to “old yellow enzyme” (OYE1) [17]. OYEs preferentially accept α,β-unsaturated 
ketones, aldehydes, nitroalkenes, and some carboxylic acids as substrates [7]. In the last decade, the 
catalytic mechanism of OYEs has been exhaustively investigated and its general principle is well 
understood: The enzymes follow a bi–bi ping–pong mechanism, which can be divided into a 
reductive and an oxidative half reaction [18]. In the reductive half-reaction, flavin mononucleotide 
(FMN) is reduced through hydride transfer from NAD(P)H, whereas in the oxidative half reaction a 
hydride is transferred from the reduced flavin to the Cβ of the activated alkene. The missing proton 
for the Cα is transferred via a tyrosine residue from the opposite site [18,19], ultimately leading to an 
anti-addition hydrogenation. 
The catalytic machinery of OYE enzymes is supported by a typical (α,β) 8-barrel (TIM-barrel) 
fold with additional secondary structural elements present (e.g., four β-strands and five α-helices in 
OYE1 [20]; six β-strands and two α-helices in 12-oxophytodienoate reductase OPR [18]). The folded 
domain is known to occur in different oligomeric states, such as monomers (PETN reductase) [21], 
dimers (OYE1) [20], tetrameters (dimers of dimers such as YqjM [22] or TOYE [23]), octamers, and 
dodecamers [23]. The oligomerization state is described to be often governed by the position and 
amino acid composition of surface loops [7]. In addition, the constitution of the loops can have an 
influence on thermostability [23]. 
Notably, amino acid sequence alignments of OYE homologs show high conservation in specific 
regions of the proteins, such as residues involved in catalysis, FMN, and substrate binding [7,15,23]. 
To account for these differences in sequence and the resulting structural features, the old yellow 
enzyme family can be further divided into five subclasses [15]. While enzyme members of the 
subclass I, also termed “classical” old yellow enzymes, and class II, introduced by Scrutton’s group 
in 2010 and dubbed “thermophilic-like” [23], have been well explored [7,14], the recently described 
class III–V are less well investigated [15,24]. 
Synthetic applications of ene reductases are manifold and range from the preparation of profens 
[25–27] and chiralγ-amino acids [28–30] to the synthesis of chiral phosphonates [31] and nitroalkanes 
[32], precursors in the synthesis of pharmaceutically active ingredients. To further promote an off-
the-shelve synthetic use of ene reductases, which can reduce the time and cost of the implementation 
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quinone reductase like ene-reductases), EnoR (enoate reductase), OYE (old y llow enzyme), MDR
(medium-chain dehydrogenase/reductase), and SDR (sho t-chain dehydrogenase/reductase); Class I
(classical OYE); Class II (thermophilic- ike OYE) and Clas V (fungal OYE).
Isolated in 1932 by Warburg and Christian from bottom-fermented brewer’s yeast (Saccharomyces
pastorianus), the first such ene reductase was named “yellow enzyme” [16]. After the discovery of
several additional members belonging to the same enzyme family the “yellow enzyme” was renamed
to “old yellow enzyme” (OYE1) [17]. OYEs preferentially accept α,β-unsaturated ketones, aldehydes,
nitroalkenes, and some carboxylic acids as substrates [7]. In the last decade, the catalytic mechanism of
OYEs has been exhaustively i vestigated and its general principle is well understood: The enzymes
follow a bi–bi ping–pong mechanism, which can be divided into a re uctive and an oxidative half
reaction [18]. In the reductive half-reaction, flavin mo onucleotide (FMN) is reduced through hydride
transfer from NAD(P)H, w ereas in the oxidative half reaction a hydride is tra sferred from the
reduced flavin to t e Cβ of the activated alkene. The missing proton for the Cα is transferred via
a tyrosine residue from the opposite site [18,19], ultimately leading to an anti-addition hydro enatio .
The catalytic machinery of OYE enzymes is supported by a typical (α,β) 8-barrel (TIM-barrel)
fold with additional secondary structural elements present (e.g., four β-strands and five α-helices in
OYE1 [20]; six β-strands and two α-helices in 12-oxo hyto ienoate reductase OPR [18]). The folded
domain is known to occur in different oligo eric states, such as monomers (PETN reductase) [21],
dimers (OYE1) [20], tetrameters (dimers of dimers such as YqjM [22] or TOYE [23]), octamers, an
decamers [23]. The ligomerization state is described to be often governed by the position and amino
acid composition of surface loops [7]. In addition, the constitution of the loops can have an influence
on ther ostability [23].
Notably, a ino acid seq ence alignments of OYE homologs show high conservation in specific
regions of the proteins, such as residues involved in catalysis, FMN, and substrate binding [7,15,23].
To account for these differences in sequence a d the resulting structural features, the old yellow enzyme
family can b further divided into five subclasses [15]. While enzyme members of the subclass I,
also termed “classical” old yellow enzym s, and class II, introduced by Scrutton’s group in 2010 and
dubbed “thermophilic-like” [23], have bee well explored [7,14], the recently described class III–V ar
less well investigated [15,24].
Synthetic applications of ene reductases are manifold and range from th preparation of
profens [25–27] and chiralγ-amino acids [28–30] to the synthesis of chiral phosphonates [31] and
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nitroalkanes [32], precursors in the synthesis of pharmaceutically active ingredients. To further
promote an off-the-shelve synthetic use of ene reductases, which can reduce the time and cost of the
implementation of a biocatalytic step into a process significantly, we set out to expand the available
biocatalytic toolbox [15]. In this context, not only the discovery and engineering of novel ene reductases
is of great utility [33], but also a careful characterization of the new biocatalysts is needed as it may
lead to the construction of a more targeted enzyme library associated with reduced screening time
and costs.
Herein, we showcase the detailed characterization of Ppo-Er1 from Paenibacillus polymyxa, an OYE
subclass III enzyme, and highlight the enzyme’s substrate scope, kinetic parameters, solvent tolerance,
as well as pH and temperature profile. The data presented may facilitate future screening and
engineering studies and, in selected cases, thus, lead to the faster adoption of an ene reductase in
chemical process development.
2. Results and Discussion
The enzyme Ppo-Er1 from P. polymyxa was discovered during the screening of 19 bacterial
wild-type strains from the Culture Collection of Switzerland, as previously described [15]. Ppo-Er1
(41.3 kDa) is characterized by a substantial sequence similarity with the old yellow enzyme YqiG
from Bacillus subtilis (50%) [34], Bac-OYE2 from Bacillus sp. (50%) [35], Lla-Er from Lactococcus lactis
(39%) [15], and LacER from Lactobacillus paracasei (47%) [36], all of which belong to the subclass III
of the OYE family. In detail, Ppo-Er1 contains a specific combination of motifs known from the
classical and thermophilic-like groups that has been found to be characteristic for class III enzymes [15]:
Gln104 and Arg228 predicted to interact with the pyrimidine ring of FMN [22], His 171, and Asn 175
proposed to interact with N1 and N3 of FMN [22,37]; Thr30 suggested to interact with isoalloxazine
ring O4 of FMN [38]; and Met29, Leu324, and Arg321, which presumably interact with the dimethyl
benzene moiety of FMN. As expected, subclass III old yellow enzyme Ppo-Er1 is thus phylogenetically
positioned between classical and thermophilic-like OYEs.
2.1. Expression and Characterization of Ppo-Er1
The ready-to-use plasmid consisting of pET-28b(+) vector and the Ppo-Er1 sequence was assembled
by Twist Bioscience and a C-terminal His6 tag for protein purification by affinity chromatography was
included. The soluble recombinant expression of Ppo-Er1 in Escherichia coli BL21 (DE3) was achieved
in terrific broth (TB) medium at 25 ◦C. Ppo-Er1 was purified by affinity chromatography using Ni-NTA
resin (Figure S1) and the cofactor FMN was reconstituted before further analysis. FMN reconstitution
(100 µM) proved necessary to obtain a fully active enzyme as without this step the enzyme preparation
only exhibited 8% (0.05 U/mg for cyclohexanone) of the expected activity (0.61 U/mg for cyclohexanone).
This effect was also described for the OYEs LacER [36] and Lla-Er [15]. In the case of LacER, for
example, the addition of FMN after purification by DEAE ion exchange chromatography increased
the activity by a factor of 92 from 0.0018 to 0.168 U/mg for the substrate trans-2-hexen-1-al. This
observation suggests that—similar to other known OYEs—the binding affinity of Ppo-Er1 to FMN
under purification conditions is low, a fact that has to be kept in mind for any following activity
analysis. The storage stability of the purified Ppo-Er1 proved to be very good, boding well for the
enzyme’s incorporation in potential enzyme screens: At −20 ◦C and in the presence of 20% glycerol,
the enzyme did not lose any activity even when stored for an extended period of time (one week),
whereas an activity drop of approximately 20% was observed after incubation for 10 days at 4 ◦C (no
additives). In contrast to a number of reported OYEs [15,39], we found that NADPH and NADH are
equally preferred physiological cofactors of Ppo-ER1 (Figure S14) allowing for maximum flexibility in
the choice of recycling system during process development. Both, the coupled-enzyme approach [40]
or the use of alternative hydride sources [41,42] will thus be conceivable options to avoid having to
add stoichiometric amounts of the coenzymes.
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The oligomeric state of Ppo-Er1 was determined via gel filtration by correlation with a commercial
gel filtration standard containing proteins of specific size. Based on this comparison, Ppo-Er1 mostly
occurs as a monomer (Figure S2) as do for example PETN from Enterobacter cloacae [21] and RmER
from Ralstonia metallidurans [43], both thermophilic-like ene reductases.
Further relevant parameters for application such as optimum pH, optimum temperature, and
long-term temperature stability were determined using the substrate cyclohexenone. The pH profile of
Ppo-Er1 was measured in Davies buffer covering pH 5 to pH 10 [44], in which the enzyme reached about
50% of the activity observed in 50 mM phosphate buffer (Figure S3). The pH profile was found to be
bell-shaped, exhibiting a narrow optimum at pH 6.5–7.5 (Figure 2). Beyond this range, enzyme activity
decreases rapidly, especially when the enzyme was pre-incubated for a longer time period (24 h) in the
measurement buffers (Figure 2). In the case of other characterized class III OYEs such as LacER [36] and
YqiG [15,34], a similar pH profile was determined albeit with a wider pH working range as indicated
by the reported optimum activities in the range of pHopt 8–9 and pHopt 6–9, respectively. Notably,
OYE enzymes belonging to other subclasses exhibit similar pH profiles as reported for Ppo-Er1, e.g.,
the “classical” XenB [45] and NemA [45] with a pHopt of 6–7.5, the “thermophilic-like” YqjM [46] and
Chr-OYE3 [47] with a pHopt of 6–8, and the class IV enzyme Ppo-Er3 [15] with a pHopt of 7–8.5.
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In terms of thermal robustness, Ppo-Er1 possesses interesting long-term stability. After 24 h 
incubation at 20 °C, enzyme activity toward cyclohexenone remained virtually unchanged, whereas 
residual activity of approximately 70% was detected after an equally long incubation time at 30 °C. 
Furthermore, short-term exposure of Ppo-Er1 to 45 °C led to only a marginal loss in activity (<10%) 
allowing the enzyme to be used for applications that require higher temperatures (Figure 3). These 
results are in line with data obtained for other class III and IV enzymes such as YqiG and Ppo-Er3, 
which have reported Topt values of 25–40 °C [15,34]. Strikingly, Ppo-Er1 retained a relative specific 
activity of >70% at temperatures as low as 10 °C making the enzyme an interesting candidate to be 
used for the transformation of thermolabile substrates such as aldehydes (Figure 3). Overall, our Ppo-
Er1 data confirm that the temperature profile of class III enzymes resembles those of their mesophilic 
counterparts of class I, for example NemA [45] with a reported Topt of 30–50 °C and OYE2p [48] with 
a Topt of 25–40 °C. Finally, we employed the ThermoFAD technique to determine the melting 
temperature of Ppo-Er1 and found that the ene reductase unfolds at Tm = 46.5 ± 1 °C (Figure S15). 
Figure 2. pH profile of Ppo-Er1 measured between pH 5 and pH 10 in Davies buffer [44]. The enzyme
was preincubated at 25 ◦C in the respective measurement buffer solution for 10 min and 24 h,
respectively, to determine the stability and activity of Ppo-Er1 in dependence of pH. Relative specific
activity corresponds 100% to an activity of 0.41 U/mg for cyclohexenone. The error bars show the
standard deviation of triplicates.
In terms of thermal robustness, Ppo-Er1 possesses interesting long-term stability. After 24 h
incubation at 20 ◦C, enzyme activity toward cyclohexenone remained virtually unchanged, whereas
residual activity of approximately 70% was detected after an equally long incubation time at 30 ◦C.
Furthermore, short-term exposure of Ppo-Er1 to 45 ◦C led to only a marginal loss in activity (<10%)
allowing the enzyme to be used for applications that require higher temperatures (Figure 3). These
results are in line with data obtained for other class III and IV enzymes such as YqiG and Ppo-Er3,
which have reported Topt values of 25–40 ◦C [15,34]. Strikingly, Ppo-Er1 retained a relative specific
activity of >70% at temperatures as low as 10 ◦C making the enzyme an interesting candidate to be used
for the transformation of thermolabile substrates such as aldehydes (Figure 3). Overall, our Ppo-Er1
data confirm that the temperature profile of class III enzymes resembles those of their mesophilic
counterparts of class I, for example NemA [45] with a reported Topt of 30–50 ◦C and OYE2p [48]
with a Topt of 25–40 ◦C. Finally, we employed the ThermoFAD technique to determine the melting
temperature of Ppo-Er1 and found that the ene reductase unfolds at Tm = 46.5 ± 1 ◦C (Figure S15).
Catalysts 2020, 10, 254 5 of 14t l sts , , x FOR PEER REVIEW    
 
 
Figure 3. The temperature profile and the temperature stability of Ppo-Er1. For the temperature 
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Ppo-Er1 was incubated at four different temperatures (4–40 °C) and measured after 24 h at 25 °C. The 
error bars show the standard deviation of triplicates. Relative specific activity corresponds 100% to 
an activity of 0.52 U/mg for cyclohexenone. 
The use of cosolvents is often a “must” in biocatalytic processes due to the presence of high 
concentrations of various organic substrates. Consequently, in many instances the solvent stability of 
enzymes needs to be optimized by enzyme engineering to generate catalysts that are compatible with 
the process conditions [49]. To verify the stability of Ppo-Er1 in the presence of a set of typical 
solvents, we thus determined the enzymatic activity over a concentration range of 10–40% of DMSO, 
DMF, cyclohexane, ethanol, and ethyl acetate. The enzyme performed best in cyclohexane (assayed 
substrate: 1 mM hexenal), which did not cause a significant loss in activity even when supplemented 
to a final volume of up to 40% in the assay. Alternatively, DMSO could be considered as a viable 
cosolvent for Ppo-Er1 as the enzyme was virtually unaffected up to a concentration of 20% v/v. Even 
at a concentration of 30% v/v DMSO, Ppo-Er1 retained a relative activity of approximately 80% (assay 
substrate: 1 mM cyclohexenone). The solvent ethanol was shown to also be a suitable choice for this 
enzyme, as it was tolerated well up to a concentration of 10% v/v. DMF or ethyl acetate, however, 
should not be used in combination with Ppo-Er1 as their presence was found to be detrimental for 
enzymatic activity. Already at a concentration of 10% v/v activity drops of 30% and 85% were 
observed, respectively (Figure 4). 
In comparison to most known old yellow enzymes, Ppo-Er1 exhibits similar solvent resistance: 
The thermophilic-like OYE YqjM [46] has been reported to remain active in an analogous 
concentration range of DMSO, DMF, and ethyl acetate as Ppo-Er1. However, an ethanol 
concentration of 10% v/v led to a strong reduction of the half-life of YqjM, which we did not observe 
in the case of Ppo-Er1. TOYE [23], another thermophilic-like OYE, was reported to exhibit a 50% loss 
of activity at an ethanol concentration of 45% corresponding to a higher stability toward this solvent 
compared to Ppo-Er1, whereas the classical PETNR [50] already lost 50% activity in the presence of 
an ethanol concentration of 20% v/v. In this context, it should be noted that organic-solvent-tolerant 
ene reductases have also been reported: FOYE1, originating from an acidophilic iron oxidizer, was 
shown to perform well in many solvent systems with up to 20% v/v solvents (ethanol, methanol, 
acetone, isopropanol, DMSO, THF) clearly outperforming all abovementioned ene reductases in 
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i re 3. The temperature profile and the temperature stability of Pp -Er1. For the temperature profile
Ppo-Er1 was incubated for 5 min at different temperatures (10–60 ◦C) and directly measured for the
conversion of substrate cyclohexenone (1 mM). For the temperature stability measure ent, Ppo-Er1
was incubated at four different temperatures (4–40 ◦C) and measured after 24 h at 25 ◦C. The error bars
show the standard deviation of triplicates. Relative specific activity corresponds 100% to an activity of
0.52 U/mg for cyclohexenone.
The use of cosolvents is often a “must” in biocatalytic processes due to the presence of high
concentrations of various organic substrates. Consequently, in many instances the solvent stability
of enzymes needs to be optimized by enzyme engineering to generate catalysts that are compatible
with the process conditions [49]. To verify the stability of Ppo-Er1 in the presence of a set of typical
solvents, we thus determined the enzymatic activity over a concentration range of 10–40% of DMSO,
DMF, cyclohexane, ethanol, and ethyl acetate. The enzyme performed best in cyclohexane (assayed
substrate: 1 mM hexenal), which did not cause a significant loss in activity even when supplemented
to a final volume of up to 40% in the assay. Alternatively, DMSO could be considered as a viable
cosolvent for Ppo-Er1 as the enzyme was virtually unaffected up to a concentration of 20% v/v. Even at
a concentration of 30% v/v DMSO, Ppo-Er1 retained a relative activity of approximately 80% (assay
substrate: 1 mM cyclohexenone). The solvent ethanol was shown to also be a suitable choice for this
enzyme, as it was tolerated well up to a concentration of 10% v/v. DMF or ethyl acetate, however,
should not be used in combination with Ppo-Er1 as their presence was found to be detrimental for
enzymatic activity. Already at a concentration of 10% v/v activity drops of 30% and 85% were observed,
respectively (Figure 4).
In comparison to most known old yellow enzymes, Ppo-Er1 exhibits similar solvent resistance:
The thermophilic-like OYE YqjM [46] has been reported to remain active in an analogous concentration
range of DMSO, DMF, and ethyl acetate as Ppo-Er1. However, an ethanol concentration of 10% v/v
led to a strong reduction of the half-life of YqjM, which we did not observe in the case of Ppo-Er1.
TOYE [23], another thermophilic-like OYE, was reported to exhibit a 50% loss of activity at an ethanol
concentration of 45% corresponding to a higher stability toward this solvent compared to Ppo-Er1,
whereas the classical PETNR [50] already lost 50% activity in the presence of an ethanol concentration
of 20% v/v. In this context, it should be noted that organic-solvent-tolerant ene reductases have also
been reported: FOYE1, originating from an acidophilic iron oxidizer, was shown to perform well in
many solvent systems with up to 20% v/v solvents (ethanol, methanol, acetone, isopropanol, DMSO,
THF) clearly outperforming all abovementioned ene reductases in terms of solvent stability [51].
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analogy to other class II, III, and IV enzymes [15,39]. In addition, carboxylic acids and esters seem to 
Figure 4. Overview of the solvent stability of Ppo-Er1 in DMSO (dimethyl sulfoxide), DMF (dimethyl
formamide), cyclohexane, ethanol, and ethyl acetate in a concentration range of 10%–40% v/v.
The standard enzyme assay was performed while the concentration of solvents was varied (substrate
for cyclohexane: 1 mM hexenal, all other solvents: 1 mM cyclohexenone). Data are shown as values
relative to an enzyme assay without cosolvent in which 100% relative conversion corresponds to
the production of 0.84 mM cyclohexanone or 0.49 mM hexanal, respectively. The error bars show
the standard deviation of triplicates, except for the 30% v/v cyclohexane point for which only two
measurements were available.
2.2. Substrate Scope, Determination of Michaelis–Menten Parameters, and Stereoselectivity
To determine the substrate profile of Ppo-Er1, the enzyme was tested for the conversion of
nineteen s ructurally diver e liphatic and cyclic alkenes bearing keton , al ehyde, nitro, carb xylic
acid, or ester moieties as electron-withdrawing groups. For thirteen substrat s, product formation by
Ppo-Er1 could b detect d. Cyclohexenone, hexenal, 2-methyl-2-penten l, 4- henyl-3-buten-2-one,
cinnami aldehyde, mal imide, and carvone (at 5 mM concentration) were converted especially well,
a d >99% conversion was obtaine withi 4 h (Table 1). Substrates not accepted by Ppo-Er1 included
α,β-unsaturat d carboxylic acids such as butenic acid, cinnamic acid, and citraconic acid as well as
the ketones 3-methyl-2-cyclohexenone and 3-methyl-2-cyclopentenone, which are characteriz d by
an additional methyl group in the β-position. T e α,β-unsaturated ster et yl crotonate was also
not converted.
Based on the obtained data, it can be concluded that the overall substrate profile of Ppo-Er1
resembl s that of other subclass III enzym s such as YqiG [15,34] and Lla-Er [15]. For example, 5 mM
of cinnamic ldehyd and yclohexenone are also well converted by Lla-Er [15] (65% ± 4.2% and 23%
± 3.1%) and YqiG [15] (58% ± 2.4% a d 55% ± 6.1%) after 1 h at 30 ◦C. Notably, however, marked
differences in substrate acceptance by class III enzymes occur for some of the investigated substrates
highlighting the importance of an in-depth substrate profiling: Whereas car one n maleimide
are very well converted by Ppo-Er1 (both: >99%), Lla-Er, for example, acc pts this co pound
only poorly (carvone: 2.6% ± 0.1%, maleimide: not converted) [15]. Diethylbenzyli enemal nate
on ersion by YqiG [15,34] (11%± 1.3%), the other hand, significantly exc eded the detected product
formations achieved by Lla-Er (<1%) [15] and Ppo-Er1 (1.2%). Moreover, 3-methyl-2-cy lopenten e,
w ich is not converted by Ppo-Er1, Lla-Er [15], and YqiG [15,34], as been shown t be accepted
by LacER [36]. Generally, we noted that Ppo-Er has a restricted substrate ac eptance for cyclic
β-methylated substra s such as 3-met yl-2-cycloh xenone and 3-me hyl-2-cyclopentenone, which
possibly results fro a difficulty in accepting substituents at the Cβ position of cyclic compounds in
the active site in analogy to other class II, III, and IV enzymes [15,39]. In additio , carboxylic acids
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and esters seem to be non-optimal alkene activating groups for this enzyme as conversion of the
corresponding substrates was low or not detectable.
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates
converted with purified enzymes as determined after 4 h at 20 ◦C (n.d.: not detected; n.s.: not soluble).
The given uncertainties show the standard deviation of triplicates.
Substrate Conversion ee kcat/Km Km kcat
Name Structure (%) (%) (mM−1 s−1) (mM) (s−1)
Maleimide
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
≥99 ± 3.7 287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62
trans-β-Methyl-β-nitrostyrene
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
81 ± 1.0 41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36
2-Methyl-2-pentenal
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicate . 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11
Cinnamaldehyde
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
he given uncertainties show the standard devi tion of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
tr ns-β-M thyl-β-nitrostyrene 
 
81  1.0  41.4  .23 . 2  . 3 4.97  .36 
2-Methyl-2-pente al 
 
≥99 ± 7.4 (S) 63 15.3  .09 .41  . 4 6.2   .11 
Cinnamaldehyd  
 
  1.5  4.6  .14 .36  . 5 5.   . 8 
Hexenal 
 
  3.4 
 
3.3  . 0 2.22  .21 7.42  .01 
Carvone 
 
  2.1 (R) 98 0.5  . 6 4.35  .69 2.20  . 8 
ycl h xenone   0.5 
 
.4  .08 1 .42 ± 1.0 5.25 ± 0.1 
itral 2   1.4 (S) 94 .2  .93 1.1   .  0.17  .04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 R) 92 .1  .2  4.93 ± 3.3 1.30  . 8 
≥99 ± 1.5 14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18
Hexenal
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β- itrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
≥99 ± 3.4 3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01
Carvone
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-p ntenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cin amaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
  .4 
 
3.3 ± 0.10 2.22  .2  7.42  .01 
C rvone 
 
≥99 ± 2.1 (R) 98 0.5  .16 4.35  .69 2.20  .08 
Cyclo exenone   0.5 
 
0.4  . 8 13.42 ± 1.0 5.25 ± 0.  
itral 2   .4 (S) 94 0.2  .93 1.12 ± 1.0 0.1   .04 
2-M thyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1  .23 14.93 ± 3.3 1.30  . 8 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08
Cyclohexenone
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Mal imi e 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0 01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
≥99 ± 0.5 0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1
Citral
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
The given uncertainties show the standard deviation of triplicates. 
Substrate Conversion ee kcat/Km Km kcat 
Name  Structure 
(%) (%) (mM−1 s−1) (mM) (s−1) 
Maleimide 
 
≥99 ± 3.7  287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 
 
81 ± 1.0  41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal 
 
≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde 
 
≥99 ± 1.5  14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal 
 
≥99 ± 3.4 
 
3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone 
 
≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 
 
0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 
  
 
76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04
2-M thyl-2 cyclohexen
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 15 
be non-optimal alkene activating groups for this enzyme as conversion of the corresponding 
substrates was low or not detectable. 
Table 1. Conversion, steady state kinetics,(a) and enantiomeric excess (ee) of various substrates 
converted with purified enzymes as determined after 4 h at 20 °C (n.d.: not detected; n.s.: not soluble). 
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trans-β-Methyl-β-nitrostyrene 81 ± 1.0 41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
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Ci namaldehyde ≥99 ± 1.5 14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal ≥99 ± 3.4 3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
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itral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
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. 0.4 (R) 92 .1 ± 0.23 .93 ± 3.3 1.30 ± 0.08
Cyclopentenone
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Maleimide ≥99 ± 3.7 287.8 ± 0.12 0.10 ± 0.01 28.78 ± 0.62 
trans-β-Methyl-β-nitrostyrene 81 ± 1.0 41.4 ± 0.23 0.12 ± 0.03 4.97 ± 0.36 
2-Methyl-2-pentenal ≥99 ± 7.4 (S) 63 15.3 ± 0.09 0.41 ± 0.04 6.27 ± 0.11 
Cinnamaldehyde ≥99 ± 1.5 14.6 ± 0.14 0.36 ± 0.05 5.27 ± 0.18 
Hexenal ≥99 ± 3.4 3.3 ± 0.10 2.22 ± 0.21 7.42 ± 0.01 
Carvone ≥99 ± 2.1 (R) 98 0.5 ± 0.16 4.35 ± 0.69 2.20 ± 0.08 
Cyclohexenone ≥99 ± 0.5 0.4 ± 0.08 13.42 ± 1.0 5.25 ± 0.1 
Citral 29 ± 1.4 (S) 94 0.2 ± 0.93 1.12 ± 1.0 0.17 ± 0.04 
2-Methyl-2-cyclohexenone 76.2 ± 0.4 (R) 92 0.1 ± 0.23 14.93 ± 3.3 1.30 ± 0.08 
5 1.7 0.03 ± 0.17 57.24 ± 9.4 1.75 ± 0.16
4-Phenyl-3-buten-2-one
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Cyclopentenone 
  
59 ± 1.7   0.03 ± 0.17 57.24 ± 9.4 1.75 ± 0.16 
4-Phenyl-3-buten-2-one 
  
≥99 ± 1.0 
  
 n.s.   
Butylacrylate   22 ± 6.5 
        
Diethyl benzyldienemalonate 
  
 
1.2 ± 0.0        
3-Methyl-2-cyclohexenone 
  
n.d.         
3-Methyl-2-cyclopentenone 
  
n.d.         
Etylcrotonate 
  
n.d.         
Butenoic acid  n.d.         
Cinnamic acid 
  
 
n.d.         
Citraconic acid   n.d.         
(a) Reactions (1 mL) were performed in potassium phosphate buffer (50 mM, pH 7.0) containing 
NADPH (175 μM) and substrate (20 μM–80 mM), depending on substrate, Ppo-Er1 (0.61 μM), and 
DMSO to solubilize the substrates. The reactions were followed continuously by monitoring NADPH 
oxidation at 340 nm for 90 sec at 25 °C. 
To complement the substrate acceptance profile, Michaelis–Menten parameters of Ppo-Er1 for 
ten diverse substrates were determined (Table 1, Figures S4–S13). Within the tested substrate range, 
Ppo-Er1 showed the highest catalytic efficiency for maleimide (kcat/Km = 287 mM−1 s−1) followed by 
trans-β-methyl-β-nitrostyrene (kcat/Km = 41 mM−1 s−1). In combination with the conversion data, the 
measured kinetic parameters (Table 1) indicate a general preference for alkenes carrying a phenyl 
substituent at the Cβ position of the substrates. Overall, Ppo-Er1′s specific activity for other typical 
≥99 ± 1.0 n.s.
Butylacrylate
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22 6.5
Diethyl benzyldienemalonate
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measured kinetic parameters (Table 1) indicate a general preference for alkenes carrying a phenyl
substituent at the Cβ position of the substrates. Overall, Ppo-Er1′s specific activity for other typical
ene reductase substrates such as carvone (kcat/Km = 0.5 mM−1 s−1) and cyclohexanone (kcat/Km =
0.4 mM−1 s−1) was found to be in a similar range as those described for other well-known OYEs such
as the classical PETNR (carvone: kcat/Km = 2 mM−1 s−1; cyclohexanone: kcat/Km = 5 mM−1 s−1) [50]
and the thermophilic-like YqjM (cyclohexanone: kcat/Km = 6.4 mM−1 s−1) [46] (Table 2). Maleimide,
however, is better converted by ene reductases from photosynthetic extremophiles such as CtOYE
(kcat/Km = 1940 mM−1 s−1) or GsOYE (kcat/Km = 399 mM−1 s−1) [52] the thermophilic-like OYERo2
(kcat/Km = 10,800 mM−1 s−1) [53] or the class III OYE YqiG (kcat/Km = 800 mM−1 s−1) (Table 2).
Table 2. Comparison of the catalytic efficiencies (mM−1 s−1) of a range of known old yellow enzymes
(OYEs) (YqiG [34], PETNR [50], YqjM [46], TOYE [23], DrER [43], RmER [43], and OYERo2 [53]) from
class I–III.
Class I Class II Class III
Substrate PETNR YqjM TOYE DrER RmER OYERo2 Ppo-Er1 YqiG
Cyclohexenone 5 6.4 0.5 2.1 0.7 0.4 22
2-Methyl-cyclohexenone 4 1.0 0.1
Cyclopentenone <0.5 1.9 0.6 0.03
Hexenal 0.60 3.3
Citral 9 0.02 0.05 0.2 6.7
2-Methyl-2-pentenal 61 0.14 15.3 18
Cinnamaldehyde 8 14.6
Carvone 2 1.5 0.5 7.5
Maleimide 10,800 287.8 800
trans-β-Methyl-β-nitrostyrene 41.4
In addition to determining the steady-state kinetic parameters, we also investigated the
stereopreference of Ppo-Er1. Based on our results with four selected substrates, Ppo-Er1 displays
a similar stereopreference to other reported OYE class III enzymes (Table 3), preferentially forming
the S-product when converting 2-methy-2-pentenal and citral and forming the R-product when
transforming carvone and 2-methyl-2-cyclohexenone. Notably, the detected ee values of Ppo-Er1 are
generally superior to values determined for YqiG and Lla-Er [15] with the only exception being the
enantiomeric excess reported for the conversion of carvone by Lla-Er (>99.9% ee). It should be noted,
however, that Lla-Er displayed a low conversion of 2.6% of 5 mM substrate after 1 h at 30 ◦C compared
to the >99% conversion of 5 mM substrate by Ppo-Er1 after 4 h at 20 ◦C.
Table 3. The enantiomeric excess of some selected OYEs (YqiG [15], Lla-Er [15], Ppo-Er3 [15], OPR1
[54], OPR3 [54], PETNR [50], YqjM [54], TOYE [23]) from classes I–IV. The values presented for YqjM
were measured as a reference for Ppo-Er1 and compared with the literature [54].
Class I Class II Class III Class IV
Substrate OPR1 OPR3 PETNR YqjM TOYE Ppo-Er1 YqiG Lla-ER Ppo-Er3
2-Methyl-2-pentenal (R) 47 (S) 78 (R) 20 (S) 55 (S) 63 (S) 33 (S) 5 (S) 67
Carvone (R) 95 (R) 82 (R) 95 (R) 98 (R) 89 (R) >99.9 (R) 91
2-Methyl-2-cyclohexenone (R) 77 (R) 62 (R) 81 (R) 92 (R) 83 (R) 11 (R) 86
Citral (S) >95 (S) >95 (S) 95 (S) 91 (S) 94
3. Materials and Methods
3.1. Materials
All chemicals were purchased from Merck (Darmstadt, Germany), VWR (Hannover, Germany),
or Carl Roth (Karlsruhe, Germany). The purchased chemicals were of the highest available purity or
of analytical grade and were used without further purification unless otherwise specified. NADPH
tetrasodium salt was ordered from Oriental Yeast Co. Ltd. (Tokyo, Japan). The plasmid (pET 28b(+)
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incl. Ppo-Er1) was ordered from Twist Bioscience (San Francisco, CA, USA). The HisTrap FF and the
HiTrap Desalting columns were ordered from GE Healthcare (Uppsala, Sweden).
3.2. Plasmid
Twist Bioscience (San Franscisco, CA, USA) cloned the synthetic gene of the codon optimized
Ppo-Er1 (Accession Nr: WP_013369181) with NdeI and XhoI in the commercial pET28b(+) vector.
3.3. Bacterial Strains and Culture Conditions
E. coli BL21 (DE3) [fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS] was purchased from New England
Biolabs (Beverly, MA, USA). E. coli strains were cultured routinely in Lysogeny broth (LB) or TB media
and were supplemented with kanamycin (50 µg mL−1). Bacterial cultures were incubated in baffled
Erlenmeyer flasks in a New Brunswick Innova 42 orbital shaker at 200 rpm and 37 ◦C. Bacteria on
agar plates were incubated in a HERATherm Thermo Scientific incubator under air. All materials
and biotransformation media were sterilized by autoclaving at 121 ◦C for 20 min. Aqueous stock
solutions were sterilized by filtration through 0.22 µm syringe filters. Agar plates were prepared with
LB medium supplemented by 1.5% (w/v) agar.
3.4. Expression
The expression of Ppo-Er1 in E. coli BL21 (DE3) was performed by inoculation of TB media (400 mL)
supplemented with kanamycin (50 µg mL−1) with an overnight culture (4 mL; 1:100). The culture
was incubated at 37 ◦C and 180 rpm until optical density OD600 = 0.5–0.8 was reached. Afterward
expression was induced by the addition of 100 µM IPTG, and incubation was continued at 25 ◦C for 18
h. Cells were harvested by centrifugation at 4500× g for 10 min at 4 ◦C and either used directly or the
pellet was stored by freezing at −20 ◦C.
3.5. Enzyme Purification
The cell disruption was performed by resuspending the pellet from a 400 mL culture in 20 mL
buffer (100 mM sodium phosphate buffer pH 7.5, 300 mM NaCl, supplemented by 30 mM imidazole)
and a single passage through a French press (2000 psi). The crude extract was separated from the cell
debris by centrifugation at 8000× g for 45 min. Purification was achieved by affinity chromatography
exploiting the C-terminal His-Tag using an automated Äkta purifier system. The crude extract was
filtered (0.45 µm) and applied to a pre-equilibrated 5 mL HisTrap FF column. The unbound protein
was washed with five column volumes of buffer supplemented with 45 mM imidazole. The elution
of Ppo-Er1 was accomplished by a three-column volume of buffer supplemented with 300 mM of
imidazole. The resulting fractions were collected and analyzed by SDS-PAGE. The fractions with
a high content of Ppo-Er1 were pooled and desalted using 50 mM sodium phosphate buffer (pH 7.5)
to remove the imidazole. This step was performed employing the Äkta purifier system using three
coupled 5 mL HiTrap desalting columns. After the system was equilibrated, the Ppo-Er1-containing
sample was applied and fractioned. The protein fractions were analyzed via the integrated online
absorption measurement at 280 nm. The protein content of the pooled purified sample was determined
by measuring the adsorption with a NanoDrop One (Thermo Fisher Scientific) system and using the
molecular weight (41.3 kDa) and extinction coefficient (λ = 280 nm = 38′390 M−1 cm−1) of Ppo-Er1 for
the calculation. The extinction coefficient was obtained by using the online calculation tool Prot pi [55].
3.6. Activity Assay
The activity measurements were recorded spectrophotometrically by observing NADPH
consumption at 340 nm for 60–90 s in a 1 mL (1 cm) plastic cuvette in the Lambda 465 (PDA
UV/VIS) system from Perkin Elmer. The biocatalytic experiments to obtain the pH and the temperature
profile were conducted in sodium phosphate buffer (50 mM, pH 7.5) using 175 µM NADPH, 1 mM
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cyclohexenone, and 0.61 µM purified Ppo-Er1. For the determination of the Michaelis–Menten
parameters, the substrate concentration was varied in the range of 20 µM–80 mM depending on the
substrate while the enzyme concentration was kept constant at 0.61 µM. For the pH profile, Davies
buffer [44] was used. All measurements were done in triplicates. Background NADPH consumption was
determined in assays in which either the enzyme or the substrate had been eliminated. The substrates
were solubilized as 1 M stock in DMSO.
3.7. Biocatalysis Reaction
The in vitro biocatalysis reaction were performed by using desalted Ppo-Er1 (with a concentration
of 12.1 µM), 5 mM substrate (1 M stock in DMSO) supplemented with 100 µM NADPH, 10 mM glucose,
and 5 µL GDH (20% w/v cell suspension). The reaction volume was adjusted to 1 mL in a glass vial
by using sodium phosphate buffer (200 mM, pH 7.0) and incubated for 4 h at 20 ◦C and 1000 rpm.
To determine the solvent stability of Ppo-Er1, the biocatalysis reaction conditions were adapted to
include 2.4 µM Ppo-Er1 and 0%–40% v/v solvent (ethanol, ethyl acetate, DMSO, DMF, cyclohexane) in
a total reaction volume of 1 mL for 50 min at 20 ◦C and 1000 rpm. All biocatalysis reactions were done
in triplicate, biocatalysis results were verified by control reactions omitting the enzyme.
3.8. GC-Analysis
One milliliter biocatalysis reactions were extracted once with 500 µL methyl tert-butyl ether (incl.
1 g/L 1-octanol as internal standard). The phase separation was achieved by centrifugation of the
biphasic sample, and the organic phase was separated and subjected to GC analysis (Table S1).
3.9. Gel Filtration
For the determination of the oligomeric state of Ppo-Er1, the Äkta purifier system employing
a HiLoad 16/600 Superdex 75 pg column (GE Healthcare (Uppsala, Sweden)) and sodium phosphate
buffer (50 mM, pH 7.5) was used. In a first step, the system was calibrated by using the gel filtration
standard from Bio Rad (1.35–670 kDa Prod. no.: #1511901). Then flavin-saturated Ppo-Er1 was applied
to system under identical conditions.
3.10. Melting Temperature
The unfolding temperature was determined by a ThermoFAD assay [56] using Rotor-Gene Q
RT-PCR machine. Protein samples (0.5–0.3 mg/mL) in 20 µL sodium phosphate buffer pH 7 were
measured using a temperature gradient from 25 to 90 ◦C, performing fluorescence measurements
every 0.5 ◦C increase after a 10 s delay for signal stabilization. The measurements were performed in
triplicates using 470 nm excitation wavelength and 510 nm emission wavelength.
4. Conclusions
Ppo-Er1 is a well-expressed, easy to purify, old yellow enzyme belonging to the recently introduced
subclass III designation. In terms of cofactor preference, the enzyme accepts NADPH and NADH equally
well, whereas pH and optimum temperature resemble those of previously described OYEs. Notably,
the enzyme exhibits only slightly reduced performance (>70% conversion of 1 mM cyclohexenone) at
lowered temperatures (10 ◦C) making it a possible candidate for the transformation of labile substrates
such as some aldehydes. In addition, the enzyme was shown to have noteworthy stability in the
presence of the solvents cyclohexane (up to at least 40% v/v), DMSO, and ethanol (up to 20% v/v).
The substrate profile analysis with a set of 19 representative alkenes allowed the establishment of
Ppo-Er1′s substrate scope highlighting its acceptance of a variety of linear and cyclic compounds with
often excellent transformation efficiencies and exquisite stereoselectivity (e.g., 98% ee for carvone).
Complementing this analysis with the determination of steady-state kinetics for ten of the substrates
allowed us to conclude that Ppo-Er1 classifies well with other subgroup III old yellow enzymes.
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In summary, our in-depth characterization of Ppo-Er1 allows the enlargement of the available panel
of ene reductases with a versatile biocatalyst having interesting synthetic properties. Its introduction
in the biocatalytic toolbox may further facilitate academic and industrial efforts when screening for
biocatalysts capable of asymmetric double bond reduction. Looking forward, Ppo-Er1′s performance
could be further optimized via enzyme and process engineering.
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